Modeling Bounded Rationality in Drug Shortage Pharmacists Using Attention-Guided Dynamic Decomposition

URL SCAN: Modeling Bounded Rationality in Drug Shortage Pharmacists Using Attention-Guided Dynamic Decomposition

FIRST LINE: Hospital pharmacists make high-stakes decisions to mitigate drug shortages under uncertainty, time pressure, and patient risk.

TEXT ANALYSIS PROTOCOL

1. THE DISSECTION

This paper is an autopsy rehearsal. It takes an active, employed human profession—hospital pharmacists—and systematically dissects their cognitive process for eventual machine replication. The framing of "bounded rationality" is a rhetorical move that pathologizes human cognition as a limitation to be corrected rather than a capability being displaced.

The paper explicitly builds two agents: an Expert Agent (mimicking current pharmacist attention patterns) and a Learner Agent (adapting those patterns over time). This is not optimization assistance for pharmacists. This is formalized displacement architecture. The paper's own conclusion—that the "primary decision is not what action to take, but where to allocate cognitive effort"—is the kill mechanism stated plainly. That is precisely what an AI system can execute without fatigue, without error costs, without unions, and without salary.

The paper dresses this up in healthcare altruism ("patient risk," "stable decision-making"), but the mechanical function is: prove that pharmacist cognition is decomposable, then prove that machines can handle the decomposition at lower cost.

2. THE CORE FALLACY

The paper's fundamental error is framing displacement as efficiency optimization. It treats pharmacists as cognitive systems that need better tooling when the actual DT-relevant dynamic is: AI does not need to perfectly replicate pharmacist judgment. It needs to be "good enough" (satisficing—acknowledged in the paper) and cheaper than human labor indefinitely.

The paper's conclusion that "attention-guided, satisficing strategies can reduce problem complexity while maintaining stable performance" is not a clinical observation. It is a replacement signal. Satisficing is sufficient for displacement. The paper accidentally confesses this: the core insight is that the attention allocation—not the clinical decisions—is the primary locus of value. AI can own attention allocation. It already does.

3. HIDDEN ASSUMPTIONS

• Transition feasibility: The paper assumes healthcare institutions will smoothly adopt AI decision-support in high-stakes pharmaceutical contexts. No analysis of liability, regulation, union resistance, or clinical trust architecture.
• Accountability vacuum: The paper optimizes decision-making but never addresses who bears responsibility when an attention-guided system fails. This vacuum is not incidental—it is the structural condition that accelerates adoption before accountability frameworks exist.
• Labor reclassification: The paper assumes "pharmacists" as a stable category. Under DT dynamics, this role either fragments into narrow servitor functions (tech operators, exception handlers) or is eliminated wholesale. The paper provides zero pathway analysis.
• Satisficing acceptability: "Good enough" decision-making in pharmaceutical contexts involves patient risk. The paper treats this as a solved problem (via simulation stability) rather than the ethical and legal minefield it represents—because that minefield slows adoption, and the paper's function is to accelerate it.

4. SOCIAL FUNCTION

This paper operates as Prestige-Layered Cognitive Automation Infrastructure. It:

• Generates academic credibility (arXiv, formal framework, agents)
• Provides institutional legitimacy for AI adoption in healthcare labor
• Frames displacement as humanitarian improvement ("stable decision-making," "reducing cognitive burden")
• Serves the transition management function: preparing the epistemic ground so that pharmacist displacement appears as natural technological progress rather than economic violence

Classify: Transition Management / Prestige Signaling / Partial Truth

The partial truth is real: drug shortages are genuinely difficult and pharmacist cognitive load is genuinely constrained. The lie of omission is that the solution being built does not primarily serve pharmacists or patients—it serves the institutions that want to reduce pharmacist labor costs while maintaining pharmaceutical supply chain control.

5. THE VERDICT

This paper is displacement infrastructure wearing optimization clothing. Under DT mechanics, hospital pharmacists face the following trajectory:

• Current state: Human labor, cognitive load, scarcity-driven stress, patient-facing risk
• Transition state: AI systems that formalize their decision architecture, train on their attention patterns, and begin handling low-complexity cases at scale
• Terminal state: Pharmacist role collapses to narrow exception handling (the irreducible 2-5% of cases) or is deskilled to system operator status

The paper's "Learner Agent" is not learning to help pharmacists. It is learning to replace them. The paper just hasn't been forced to say that part out loud yet—because doing so before the infrastructure is deployed would trigger regulatory and public resistance. The social function of this paper is to make that resistance unnecessary by the time the conclusion becomes explicit.

Pharmacist viability (DT lens): Fragile at 2 years, Terminal at 5-7 years. The moat is regulatory gatekeeping and liability assignment. The erosion mechanism is cost pressure on hospital systems combined with AI system performance improvements. That gap is closing.

Survival path for individual pharmacists: Sovereign (own the AI system? implausible), Servitor (become the person who validates the AI's pharmaceutical decisions? possible but shrinking), or Hyena (specialize in the cases the AI cannot handle, which will be the most dangerous and least compensated cases). There is no clean exit.